HSLN CMOS Camera System
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The project centers on advancing light scattering microscopy techniques to characterize gene delivery nanoparticles used in emerging gene therapies, addressing critical heterogeneity issues that compromise treatment safety and efficacy. Led by the Biosystems and Biomaterials Division within NIST’s Material Measurement Laboratory, the initiative seeks to enable rapid, multi-attribute measurements of individual nanoparticles’ physical properties, accelerating the development and refinement of gene therapies for complex diseases. The effort is tied to the HSLN CMOS Camera System solicitation, issued under NAICS code 334516 by the Department of Commerce, National Institute of Standards and Technology, with a response deadline of August 19, 2026. The work will be performed at NIST’s facility in Gaithersburg, Maryland, and primary technical contact is Rene D. Edwards, supported by Robert Singman. The solicitation is open as a combined opportunity without set-aside classification, targeting innovation in precision measurement systems critical to next-generation medical manufacturing.
General Info
Agency
NAICS
Place of Performance
Gaithersburg, MD, 20899, USASet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The gene therapy manufacturing innovations in measurement sciences (IMS) project, in the Biosystems and Biomaterials Division, Material Measurement Laboratory, National Institute of Standards and Technology, aims to develop light scattering microscopy methods to characterize gene delivery particles. Emerging gene therapy treatments use gene delivery nanoparticles, such as viral vectors and non-viral carriers, to cure intractable diseases. These manufactured particles suffer heterogeneity issues that hinder treatment efficacy and safety. This project aims to develop light-scattering microscopy methods to enable rapid, multi-attribute measurements of individual gene therapy nanoparticles’ physical characteristics, speeding the development of new treatments and improving their efficacy and safety.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Commerce Nist
Same awarding agency
